Fact CheckerSign in

NCT04864990Completed

Dyspnea and Idiopathic Pulmonary Fibrosis

Dyspnea in Idiopathic Pulmonary Fibrosis (IPF): Multidimensional Assessment and Correlations With Lung Function

Source: ClinicalTrials.gov · Last updated 7 Apr 2026

Brief summary (registry, in English)

Longitudinal prospective exploratory study on the evolution of dyspnea, in its sensory and affective dimensions, in patients followed for idiopathic pulmonary fibrosis (IPF), between inclusion and a 6-month evaluation

Status (registry)
Completed
Study type
Observational
Enrollment
51 (actual)
First submitted
27 Apr 2021
Start date
22 Oct 2021
Primary completion date
7 Apr 2025
Lead sponsor
University Hospital, Lille
NCT number
NCT04864990

What you commit to

  • Study type: Observational
  • Participants enrolled: 51
  • From 22 Oct 2021 to the primary completion date, 7 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • diffuse interstitial lung disease other than IPF
  • other significant chronic pathology that may cause dyspnea: chronic obstructive pulmonary disease, asthma, heart failure, anemia, obesity (non-exhaustive list), except for pulmonary hypertension

Who the study is looking for

  • diagnosis of IPF according to ATS/ERS guidelines
  • dyspnea at rest (VAS ≥ 1) or on exertion (mMRC ≥ 1)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hop Calmette Chu Lille
Coordinator of this site? Confirm its status		LilleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.